However, the cross-sectional nature of the current study still could not rule out the possibility that the elevation of serum asprosin in MetS might have been a compensatory upregulation for counteracting the metabolic stress produced by adiposity, hyperglycemia, or hyperlipidemia. This evidence concerns the gene FBN1 and hyperlipidemia.